Taiwan Exosome Achieves MOHW GTP Certification, Expands into Clinical-Grade NK Cell Production to Drive Growth in Regenerative Medicine

Exosome Technology on the Rise — Taiwan Exosome’s Strategic Blueprint for Global Market Expansion

To enhance the overall operational efficiency of the company, the Board of Directors of Medigen Biotech Corp has resolved to form a strategic alliance with Taiwan Exosome Company.

Natural is the best！National-level Biotechnology Center dedicated to research and development「Taiwanese endemic plant-Chenopodium formosanum」

New Breakthrough in Regenerative Medicine！Dr. Du Yuan-Kun's Research:Exosomes Outperform Stem Cells

Research in regenerative medicine is a highly discussed topic in today's medical field. The research team led by Dr. Du Yuan-Kun, a domestic authority in neurological treatment from E-Da Hospital, has found that "exosomes" can effectively repair nerve injuries. This represents an important breakthrough in neuroregenerative medicine, and the results have been published in an international journal.